Edwards Lifesciences Corporation v. Meril GmbH, Meril Life Sciences Pvt. Ltd., Meril Italy S.r.l.

bioMérieux Deutschland GmbH, bioMérieux Italia S.p.A., bioMérieux SA, bioMérieux Austria GmbH, bioMérieux Benelux BV, bioMérieux Portugal, Lda.vsLabrador Diagnostics LLC

In this complex UPC case involving bioMérieux and Labrador Diagnostics, the Court issued a critical procedural order following an interim conference. Recognizing that the patent EP 3 756 767 B1 faced an overwhelming number of invalidity attacks, the Panel mandated that the challenging party (bioMérieux) significantly narrow its focus. This ruling emphasizes the need for legal rigor and strategic clarity in complex revocation proceedings, ensuring the oral hearing remains focused on the most promising grounds of attack.

Amgen N.V.vsRegeneron Pharmaceuticals Inc.

This UPC Court of Appeal decision concerns the withdrawal of an appeal filed by Amgen against a prior ruling in infringement proceedings. The case, involving major biotech players like Regeneron and Sanofi, was ultimately withdrawn because the parties reached an out-of-court settlement. Although the court permitted the procedural withdrawal, it strictly denied Amgen's request for reimbursement of court fees, highlighting the precise application of UPC Rules of Procedure regarding timing and fee recovery.

ZTE CorporationvsSamsung Electronics Italia S.p.A, Samsung Electronics France, Samsung Electronics GmbH, Samsung Electronics Co., Ltd., Samsung Electronics Benelux B.V., Samsung Electronics Romania S.R.L.

This UPC decision addresses a critical procedural issue concerning the valuation of cases involving Standard Essential Patents (SEPs) and FRAND counterclaims. The Court ruled that a FRAND counterclaim significantly expands the scope and value in dispute beyond the initial infringement action, distinguishing it from a simple defense or a revocation counterclaim. This ruling clarifies that SEPs litigation can involve complex valuations based on licensing terms, even if those fees exceed standard infringement claim values.

Solvay Specialty Polymers Italy S.p.A.vsZhejiang Fluorine Chemical New Material Co., Ltd.

This UPC decision addressed a procedural dispute regarding the composition of a confidentiality club in an ongoing infringement/revocation action involving Solvay Specialty Polymers and Zhejiang Fluorine Chemical. The Court confirmed the initial order, upholding the inclusion of non-employee experts from the claimant's economic unit. The ruling clarifies that access to confidential information is not strictly limited to direct employees, significantly broadening who can be included for effective litigation.

Network System Technologies LLCvsVolkswagen AG, Audi AG, Texas Instruments Incorporated, Texas Instruments Deutschland GmbH

This UPC CFI decision addresses preliminary objections raised by Network System Technologies LLC (NST) against major automotive and semiconductor players regarding patent EP 1 552 399 B1. The Court partially dismissed NST's arguments concerning jurisdiction, standing, and the scope of infringing embodiments. Crucially, the court ruled that complex issues, such as damages related to the UK market or validity questions already pending elsewhere, must be addressed in the main proceedings to ensure procedural efficiency. This ruling signals a pragmatic approach by the UPC CFI, balancing the need for preliminary filtering with the goal of efficient case management.